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ABSTRACT
Correct spatial and temporal control of cell proliferation is of fundamental 
importance for tissue homeostasis. Its deregulation has been associated with several 
pathological conditions. In common with almost every aspect of plant and animal biology, 
cell proliferation is dominated by day-night rhythms generated by the circadian clock. 
However, our understanding of the crosstalk between the core clock and cell cycle control 
mechanisms remains incomplete. In this study, using zebrafish as a vertebrate model 
system, we show that the nuclear localization of the Y-box binding protein 1 (YB-1), a 
regulator of cyclin expression and a hallmark of certain cancers, is robustly regulated by 
the circadian clock. We implicate clock-controlled changes in YB-1 SUMOylation as one of 
the mechanisms regulating its periodic nuclear entry at the beginning of the light phase. 
Furthermore, we demonstrate that YB-1 nuclear protein is able to downregulate cyclin 
A2 mRNA expression in zebrafish via its direct interaction with the cyclin A2 promoter. 
Thus, by acting as a direct target of cyclic posttranslational regulatory mechanisms, YB-1 
serves as one bridge between the circadian clock and its cell cycle control.
INTRODUCTION
The circadian clock generates day-night rhythms in 
most aspects of physiology and behaviour [1]. Central to 
the circadian timing system is a pacemaker that oscillates 
with a period of circa 24 hours and is reset on a daily 
basis by environmental signals such as light, food or 
temperature, via input pathways. In turn, the master clock 
regulates physiology and behaviour via clock output 
pathways [1, 2]. 
At the core of the circadian clock mechanism is a 
transcription-translation feedback loop, which requires 
approximately 24 hours to complete one cycle. In 
vertebrates, the transcription factors CLOCK and BMAL 
activate expression of Period (Per) and Cryptochrome (Cry) 
genes, via binding to E-box enhancers in their promoters. 
Per and Cry in turn inhibit their own transcription by 
blocking CLOCK/BMAL driven transcriptional activation 
[3]. Additional transcriptional regulatory loops stabilize 
the entire timing mechanism [4]. Furthermore, cyclic post 
translational modifications, protein turnover and changes 
in the sub-cellular localization of key clock components all 
combine to reinforce the core clock mechanism’s timing 
function [5–7].
One key mechanism regulated by the circadian 
clock is the timing of cell proliferation and circadian 
clock disruption has been associated with several 
pathological conditions [8–10].  Clock components have 
been implicated in controlling the expression of cell cycle 
regulatory genes in order to “gate” critical cell cycle 
steps to times of day when there is a reduced exposure to 
damaging ultraviolet light. Thus, the expression of several 
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mammalian cell-cycle control genes such as Wee-1 and 
p21 has been found to be regulated in a circadian manner 
[11–13]. In addition, it has been shown that the clock has 
an impact on the cell cycle also through direct protein-
protein interactions [14]. Other clock-controlled cell cycle 
regulators include c-Myc, Mdm2, the D1, A and B cyclins 
and the tumor suppressor p53 [10]. There is also evidence 
that DNA damage can phase advance circadian rhythms 
via its effect on progression of the cell cycle [15]. Thus, 
the cell cycle can in turn also control the circadian clock. 
Therefore, understanding how these two key cellular 
oscillators, the clock and cell cycle, are inter-connected 
at the molecular level has become a major goal in the last 
few years.
The zebrafish (Danio rerio) has been established 
as one of the vertebrate model systems for studying the 
interplay between cell proliferation and the circadian 
timing system. In zebrafish, key cell cycle regulators, 
notably cyclins, are clock regulated and the circadian 
clock generates daily rhythms of S, as well as M phase by 
a cell-autonomous mechanism [16–19]. Most vertebrate 
tissues contain independent “peripheral” circadian 
clocks. However, while in mammals light entrainment of 
peripheral clocks occurs indirectly via the retina and the 
central clock of the suprachiasmatic nucleus (SCN) [20], 
zebrafish peripheral clocks are entrained by direct exposure 
to light [21]. In turn, direct exposure to light-dark cycles 
result in high amplitude rhythms of cell proliferation in 
zebrafish cells and tissues.
One of the key regulators of cyclin expression 
during cell cycle progression [22] is the Y-box binding 
protein 1 (YB-1, YBX-1). High YB-1 levels are typical 
of regenerating and proliferating cells and its abnormally 
elevated expression is a hallmark of cancer progression 
[23]. YB-1 is a DNA/RNA binding protein involved in 
almost all DNA and mRNA-dependent process, including 
DNA replication and repair, transcription, pre-mRNA 
splicing and translation. This protein is composed of 
three domains: a protein-protein interaction A/P rich 
N-terminal domain; a five stranded β-barrel CSD (Cold 
shock domain) [24] and a large C-terminal domain 
involved in controlling the subcellular localization of 
the protein [22, 25–27]. Although most YB-1 is located 
in the cytoplasm, recent evidence has shown that YB-1 
can shuttle between the nucleus and the cytoplasm 
[28]. In the nucleus, YB-1 orchestrates expression of 
proliferation-related genes, whereas in the cytoplasm 
it associates with mRNA and directs translation. YB-1 
relocalization from the cytoplasm to the nucleus at 
the G1/S phase transition has been associated with its 
function of regulating cyclin gene expression [22, 29, 30]. 
In this regard, in the nucleus YB-1 protein has been 
demonstrated to bind DNA as well as RNA, in a 
sequence-specific fashion to an inverted CCAAT box 
sequence (5′- CTGATTGGC/TC/TAA - 3′), termed the 
Y-box [31]. 
Here, using zebrafish as a model, we implicate YB-1 
as one of the links between the circadian clock and the 
control of cell cycle progression. We reveal a circadian 
clock control of YB-1 sub-cellular nuclear localization 
involving cyclic changes in SUMOylation and that this 
regulation is, at least in part, responsible for circadian cell 
cycle regulation.
RESULTS
Clock regulation of nuclear zfYB-1 
We have previously shown that the transcription of 
cell cycle control genes, including zfcyclin A2 and zfcyclin 
B1, is regulated by the circadian clock in the adult zebrafish 
caudal fin [16]. Given the central role played by YB-1 in 
the control of the cell cycle, we wished to investigate its 
involvement in circadian clock-regulated cell proliferation in 
zebrafish. It is well documented that the regulation of gene 
expression exerted by the human YB-1 protein is mainly 
due to dynamic changes in its nuclear localization [22, 32]. 
Therefore, based on the high homology between human 
and zfYB-1 (Supplementary Figure S1), we performed 
immunohistochemical analysis of zebrafish caudal fins 
at two different times during the light-dark cycle (14:10) 
using three different antibodies raised against full length, 
the N-terminal and the C-terminal portions of the human 
YB-1 protein, named: α-YB-1 F, α-YB-1 N-ter and α-YB-
1 C-ter, respectively  (Figure 1 and Supplementary Figure 
S2A–S2C and Supplementary Table S4).  With all three 
antibodies we observed an enriched nuclear localization at 
zeitgeber time (zt) 3 (day time) compared with zt 15 (night 
time), where zt 0 is defined as “lights on“ and zt 14 “lights 
off” (Figure 1A, 1B and Supplementary Figure S2B, S2C 
and Supplementary Table S1 for statistical analysis). This 
daily change in zfYB-1 nuclear localization, was confirmed 
by western blot analysis of fin nuclear extracts harvested at 
6 hourly intervals during 2 Light/Dark (LD) cycles (Figure 
2). A statistically significant sinusoidal rhythm in the nuclear 
expression of immunoreactive zfYB-1 with a peak at zt 3 
and a trough at zt 15 was observed (Figure 2A, 2B and 
Supplementary Table S1 for statistical analysis). 
Consistent with previous studies where multiple 
YB-1 immunoreactive bands were associated with 
complex post translational modifications [27, 31, 33], we 
also observed differences in the number and molecular 
weight of immunoreactive bands depending on the 
antibody used (ranging between 45 and 60 kDa). In 
addition, the oscillation of nuclear YB-1 expression 
persisted under constant conditions (constant darkness, 
DD) showing a circadian clock regulation rather than 
simply a light-dependent YB-1 rhythmicity (Figure 2C and 
Supplementary Figure S2D and Supplementary Table S1). 
Then, using a combination of approaches based on siRNA, 
recombinant protein and immunoprecipitation assays, we 
confirmed that the immunoreactive bands observed using 
Oncotarget6195www.impactjournals.com/oncotarget
the YB-1 antibodies, indeed correspond to zfYB-1 protein 
(Supplementary Figure S3A–S3D). 
One frequently encountered feature of genes that 
serve to bridge the circadian clock with its output pathways 
is that their mRNA expression exhibits clock driven 
rhythms. We thus performed a high-resolution qRT-PCR 
analysis of zfYb-1 mRNA levels in caudal fins prepared 
from zebrafish raised under LD cycles and then transferred 
to constant darkness (DD). At the RNA level, zfYb-1 
showed no significant circadian rhythm (Supplementary 
Figure S4A and Supplementary Table S1), unlike for 
zfper1b and zfcyclin A2 which both show a predominant 
circadian clock regulation (Supplementary Figure S4B, 
S4C and Supplementary Table S1). However, basal zfYb-1 
mRNA levels did show a progressive increase after 
transfer to constant darkness implicating light in setting 
the levels zfYb-1 mRNA expression (Supplementary 
Figure S4A and Supplementary Table S1).
Cell autonomous regulation of nuclear zfYB-1 by 
the circadian clock 
Consistent with a cell autonomous clock-regulation, 
immunohistochemical and western blot analysis also 
revealed a robust oscillation of zfYB-1 nuclear protein in 
zebrafish PAC-2 cells (Figure 3A, 3B and Supplementary 
Figure S5A, S5B and Supplementary Table S1), although 
compared with fins, levels remained elevated in the nuclei 
for a longer period (peak zt3-9). We next wished to test 
whether the observed 24 h rhythmicity of nuclear zfYB-1 
was directly driven by the core circadian clock mechanism 
or merely reflected clock-dependent rhythmicity of cell cycle 
progression. With this goal, we explored the effect of genetic 
clock disruption or cell proliferation arrest upon zfYB-
1 nuclear rhythmicity. Specifically, in the first approach 
we employed PAC-2 cells stably expressing a dominant 
negative form of the zfCLOCK1 protein, CLOCK1 DN, 
Figure 1: zfYB-1 cellular localization in zebrafish caudal fins. (A) Immunofluorescence analysis of zfYB-1 protein in the caudal 
fin at ZT3 (light phase) and ZT15 (dark phase) using α-YB-1 N-ter antibody. Panels also show DAPI staining and Merge, which combines 
both the DAPI and YB-1 signals. White and black bars indicate the corresponding lighting conditions. (B) Quantification of the panel A.
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which has been show to disrupt core clock function 
(Supplementary Figure S5C–S5E) [34].  In CLOCK1 DN 
cells exposed to a LD cycle, we observed no significant 
rhythmicity in nuclear zfYB-1 protein (Figure 3C, 3D 
and Supplementary Table S1). In the second approach, we 
inhibited PAC-2 cell proliferation by serum deprivation at 
a high level of cell confluence.  Under this condition, we 
observed rhythmicity of nuclear zfYB-1 levels under LD 
cycles, which also persisted on the second day following 
transfer to DD conditions (Supplementary Figure S5F and 
Supplementary Table S1). Together, these data confirm that 
rather than simply reflecting clock-dependent rhythmicity of 
cell cycle progression, zfYB-1 nuclear oscillation is a target 
of the CLOCK/BMAL-based core clock mechanism.
Given the importance of YB-1 function in 
mammalian cells, we also wished to explore whether this 
circadian clock regulation of YB-1 nuclear localization is 
an evolutionary conserved mechanism. Thus, we entrained 
the circadian clock in human HEK 293 cells via transient 
treatment with dexamethasone and then assayed nuclear 
YB-1 levels during the subsequent 48 h (Figure 4). In 
treated cells, clock synchronization was confirmed by 
circadian, antiphase rhythms of mRNA expression in 
two core clock genes, hper2 and hbmal1 (Figure 4A, 4B 
and Supplementary Table S1).  In these cells, we also 
observed a circa 24 h oscillation of nuclear YB-1 protein 
(Figure 4C, 4D and Supplementary Table S1). Therefore, 
all our results point to the cell-autonomous circadian clock 
finely tuning the nuclear localization of the zfYB-1 protein 
via an evolutionary conserved mechanism. 
YB-1 SUMOylation in PAC-2 cells
How does the clock regulate zfYB-1 nuclear 
localization? One mechanism that has been implicated in 
clock-directed shuttling of proteins between the nucleus and 
cytoplasm is SUMOylation [5, 35]. SUMOylation has been 
documented to time the nuclear entry of the BMAL1 clock 
protein. Using GPS-SUMO 1.0 software we identified three 
potential conserved SUMOylation target sites in the zfYB-
1 protein, one of which is a canonical inverted site (DSKA 
in position 287–290) and the other two are non-canonical 
sites (TKED 60–63 and EKRE 151–154) (Supplementary 
Figure S1). Extracts from PAC-2 cells immunoprecipitated 
(IP) at zt 3 with each of the three YB-1 antibodies 
independently, were subjected to immunoblotting for 
SUMO-1. Our results showed that the IP proteins from 
all three YB-1 antibodies were also recognized by the 
SUMO-1 antibody, consistent with the presence of 
SUMOylated YB-1 in zebrafish (Figure 5A). Furthermore, 
overexpression of the SUMO-conjugating enzyme UBC9 
resulted in an increase in the overall quantity of zfYB-1 
nuclear protein at zt 3 and also an increase in molecular 
weight observed at zt 15 (Figure 5B and Supplementary 
Figure S5B for comparison). To explore how the clock 
could regulate the YB-1 SUMOylation events, we next 
investigated the possibility that the expression of a 
subset of genes involved in SUMOylation could also be 
clock regulated.  Real time qRT-PCR analysis in PAC-2 
cells exposed to a LD cycle followed by DD conditions 
revealed daily rhythmic expression of zfubc9 (zfube2ia, 
zfube2ib), zfsumo1, zfsae1 (SUMO1 activating enzyme 
subunit 1) and zfpias1 (E3 SUMO-protein ligase PIAS1) 
with a peak around the light–dark transition, which also 
persisted in most cases under DD conditions (Figure 5C, 
Supplementary Figure S6 and Supplementary Table S1). In 
addition, western blot analysis of PAC-2 cells for proteins 
covalently linked with SUMO-1 groups showed a day-
night rhythm in the global levels of nuclear SUMOylated 
protein that is consistent with the timing of zfYB-1 nuclear 
localization (Figure 5D). Therefore, together these data 
point to a more general control of protein SUMOylation by 
the circadian clock rather than only YB-1.  
Inhibition of zfcyclin A2 expression by zfYB-1
Previous reports have demonstrated that YB-1 plays a 
key role in regulating cell proliferation. In the nucleus, YB-1 
orchestrates expression of many proliferation-related genes. 
Therefore, we wished to explore the functional consequences 
of daily changes in nuclear YB-1 levels in zebrafish cells. 
FACS analysis of PAC-2 cells over expressing zfYB-1 
and exposed to a LD cycle assayed at 6 hourly intervals 
during 24 h, showed a loss of cell cycle rhythmicity with 
an elevation in the proportion of cells in S and G2/M phase 
and a reduction in G0/G1 cells (Supplementary Figure S7A). 
Therefore, YB-1 has an impact on the dynamics of cell cycle 
progression in zebrafish cells.
It has been previously shown that the mRNA 
expression of cyclins in zebrafish tissues is clock 
regulated [16, 18, 19]. Consistently, we confirmed the 
clock regulation of zfcyclin A2 mRNA expression in 
PAC-2 cells (Supplementary Figure S7B). To address 
the role of zfYB-1 in cell cycle control we analyzed the 
contribution of zfYB-1 to the regulation of zfcyclin A2 
mRNA expression. Thus, we cloned a 447 bp fragment 
of the zfcyclin A2 promoter including its 5′-UTR region, 
upstream of a luciferase reporter (zf cyclin A2 prom). This 
region contains 4 putative YB-1 binding sites, 3 of them 
in the promoter and 1 in the 5′UTR region (Supplementary 
Figure S7C). Expression of this reporter construct in cells 
exposed to LD cycles increases progressively over the 
course of the assay but at a significantly higher rate during 
the dark phase (Figure 6A and Supplementary Figure 
S7D and Supplementary Table S1). Consistent with this 
reflecting regulation by the circadian clock, in transfected 
CLOCK1 DN cells this rhythmicity was not observed 
(Figure 6A and Supplementary Table S1). The higher 
cyclin A2 reporter gene expression during the dark period 
correlates with lower nuclear levels of zfYB-1 protein (see 
Figure 3A, 3B). In support of zfYB-1 playing a negative 
regulatory role, we observed a dose dependent inhibition 
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Figure 3: Nuclear zfYB-1 expression in PAC-2 and CLOCK1 DN cells. (A, C) Immunofluorescence analysis and quantification 
of nuclear levels of immunoreactive zfYB-1 in PAC-2 (A) and CLOCK1 DN (C) cells using the α-YB-1 N-ter antibody. Cells maintained 
under an LD cycle were fixed at 4 time points (ZT). A Merge of the DAPI and YB-1 staining images are shown. (B, D) Western blot analysis 
(right) and quantification (left) of α-YB-1 levels in fin nuclear extracts in PAC-2 (B) and CLOCK1 DN (D) cells under LD conditions and 
normalized for H3 expression (α-H3). Quantification was expressed as % of gray scale relative to the highest peak time point  (ZT 9) and is 
plotted on the y-axis. ZT times are plotted on the x-axis. Statistically significant differences between peak and trough points are indicated 
by asterisks (*). Results of the CircWave analysis are represented in Supplementary Table S1.
Figure 2: zfYB-1 protein expression in caudal fins. Western blot analysis and quantification of zfYB-1 levels in nuclear extracts 
under LD cycles (A, B) or during the second day in constant darkness, DD (C). The specific antibody used to detect YB-1 protein is 
indicated above each panel. An α-H3 antibody was used to provide a loading control. Vertical “brackets” on the left side of the panels A 
and B demarcate the YB-1 immunoreactive bands that were quantified using Image Lab™ Software. Quantification was expressed as % of 
gray scale relative to the highest peak of expression and is plotted on the Y-axes. Statistical significance between peak and trough points 
is indicated by asterisks where p < 0.05, p < 0.001 and p < 0.0001 are represented by *, ** and *** respectively. Results of the CircWave 
analysis are represented in Supplementary Table S1.
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of zfcyclin A2 promoter expression after co-transfection 
with the expression constructs for zebrafish YB-1 (5′Myc-
tag or 3′GFP-tag zfYB-1) and human YB-1 (3′GFP-tag 
hYB-1) (Figure 6B, 6C and Supplementary Figure S3D 
for controls) in PAC-2 cells. Finally, using a chromatin 
immunoprecipitation (ChIP) assay, we revealed a direct 
interaction between zfYB-1 and the zfcyclin A2 promoter 
(Figure 6D and Supplementary Figure S7E). Therefore, 
together our results are consistent with a role of zfYB-1 in 
the circadian clock control of cyclin A2 expression.  
DISCUSSION
Circadian rhythmicity is one of the defining 
features of normal cell cycle progression in many highly 
proliferative tissues in vivo. Furthermore, frequent 
disruption of the circadian clock has been linked with 
an increased risk of many pathologies including cancer. 
For this reason, a major goal is to understand the links 
between the core clock mechanism and key cell cycle 
control systems. Here, using the zebrafish as a model, 
we have implicated YB-1 as one such element. The sub-
cellular localization of this protein changes significantly 
with the time of day and high nuclear levels are associated 
with the early day period. These dynamic changes in YB-1 
location are driven by the cell autonomous circadian clock 
mechanism and involve SUMOylation, a post-translational 
modification already implicated in core clock function [5]. 
We show that in the nucleus, YB-1 physically associates 
with the cyclin A2 gene 5′ regulatory region and down-
regulates its expression.
Previous findings have pointed to considerable 
complexity in YB-1 function consistent with a central 
role in the regulation of cell proliferation.  However, the 
majority of these studies have focused on the role of YB-1 
in tumorigenesis with comparatively little attention being 
applied to its normal physiological function. Although 
most YB-1 is located in the cytoplasm, recent evidence 
has shown that YB-1 can shuttle between the nucleus and 
the cytoplasm [28]. In the nucleus, YB-1 orchestrates 
expression of proliferation-related genes, whereas in 
the cytoplasm it associates with mRNA and regulates 
translation. Here we present data linking high nuclear 
levels of YB-1 with repression of cyclin A2 expression. 
Cyclin A2 is synthesized at the onset of S-phase and 
then localizes to the nucleus where it is implicated in the 
initiation and progression of DNA synthesis. Our findings 
are consistent with previous results implicating YB-1 
as a cell cycle stage-specific transcription factor [22] 
present in the nucleus at the boundary between G1 and 
S phase of the cell cycle. However, the precise manner 
whereby YB-1 regulates cyclin gene expression remains 
Figure 4: hYB-1 expression in clock synchronized HEK293 cells. (A, B) Real time qRT-PCR analysis of hper2 and hbmal1 
expression in HEK293 cells during 48 hours following transient treatment with 100 nM of Dexamethasone. Relative mRNA levels are 
plotted on the y-axis. Times after DEX treatment are plotted on the x-axis. Levels of h-gapdh mRNA were used for normalization. Results 
of the CircWave analysis are represented in Supplementary Table S1. (C) Western blot analysis using the α-YB-1 N-ter antibody in HEK293 
cell nuclear extracts prepared after DEX treatment.  H3 expression was used as a loading control. (D) Quantification analysis of panel (C). 
Quantification was expressed as % of gray scale relative to the highest peak time point  (24 hrs) and plotted on the y-axis. Times after DEX 
treatment are plotted on the x-axis. The result of the CircWave analysis is represented in Supplementary Table S1.
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uncertain. Nevertheless, it is tempting to speculate that 
the clock control of YB-1 might serve as part of a more 
general mechanism to restrict DNA replication to a 
specific temporal window to minimize the impact of UV 
light-induced DNA damage. However, given the multiple 
cellular mechanisms which involve YB-1, this clock 
related function is almost certainly not the only role played 
by the YB-1 protein. 
Many lines of evidence also point to tight control 
of the timing of DNA repair processes during the day-
night cycle. Thus, robust circadian rhythmicity of DNA 
replication which is anti-phase to that of DNA repair 
has been reported [36]. Furthermore, in zebrafish the 
expression of many genes involved in DNA repair is 
strongly induced by light, thus leading to an increase in 
DNA repair capacity during periods of maximum sunlight-
induced DNA damage. In addition, DNA damage itself 
has been shown to constitute a zeitgeber for the circadian 
clock [15]. Thus, circadian clock gating of the cell cycle 
may also optimally time DNA damage repair. In this 
respect, it is interesting to note that nuclear YB-1 has been 
demonstrated to have anti-apoptotic properties based on 
its ability to coordinate DNA excision repair function and 
protect cells against damaging agents [37]. Furthermore, 
various forms of stress, including oxidative, genotoxic 
stress and hyperthermia induce nuclear translocation 
of YB-1 [31, 38] implicating YB-1 in stress and DNA 
damage responses.
Cell autonomous, circadian clock control of cellular 
processes frequently occurs at the level of transcription 
initiation. Circadian rhythms in the expression of many 
clock-controlled genes (ccgs) are directed by circadian 
E-box enhancer promoter elements that represent the 
regulatory targets of the core clock proteins CLOCK and 
BMAL1. However, a host of other proteins, including 
kinases and phosphatases [39], chromatin modifiers 
[40] and RNA-binding factors [41] in turn play essential 
roles in conferring robustness on the core circadian 
clock mechanism. YB-1 is constitutively expressed in 
proliferating tissues and performs a multitude of cellular 
 Figure 5: zf YB-1 SUMOylation. (A) Western blot analysis with the α-SUMO-1 antibody of IPs prepared from total cell extracts using 
each of the three α-YB-1 antibodies. Input and negative controls are indicated. (B) Western blot analysis using the α-YB-1 C-ter antibody in 
PAC-2 cell nuclear extracts prepared at ZT3 and ZT15 under an LD cycle in the absence or presence of over-expressed SUMO-conjugating 
enzyme UBC9 (+Ubc9). H3 expression was used as a loading control. (C) Real time qRT-PCR analysis of zfubc9b expression during 
exposure to a LD cycle followed by transfer to DD. Relative mRNA levels are plotted on the y-axis. ZT and CT times are plotted on the 
x-axis. β-actin mRNA was used for normalization. Statistical significance between peak and trough values in LD and in DD are indicated 
by asterisks. (D) Western blot analysis of SUMO-1 immunoreactive proteins in nuclear extracts prepared from cells under LD cycles. H3 
expression was used as a loading control. Results of the CircWave analysis are represented in Supplementary Table S1.
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functions, thus it is predictable that certain YB-1 functions 
are regulated by reversible post-translational modifications 
(PTM) rather than transcriptional mechanisms. In 
this regard, our results implicate SUMOylation in the 
clock-controlled translocation of YB-1 into the nucleus. 
Interestingly, circadian rhythmicity in the SUMOylation 
of the core clock protein, BMAL1, that is mediated by 
CLOCK, has been implicated in the regulation of nuclear 
entry [42]. Furthermore, our data point to general circadian 
rhythmicity in the mechanisms controlling SUMOylation. 
Thus, we speculate that YB-1 is the target of a cycling 
SUMOylation mechanism that relays timing information 
both within and outwards from the core clock mechanism.
Among the hallmarks of cancer, genome instability 
and mutations in cell cycle genes are recurring enabling 
factors [10]. Indeed mutations in cell cycle genes have 
been encountered in 90% of human cancers [43]. However, 
disruption of normal circadian clock function has also been 
linked with tumorigenesis [44]. At an epidemiological 
level, shift work, chronic jet lag and other environmental 
factors impacting on circadian clock function are also 
linked with increased cancer development and disrupted 
cell proliferation. Many human cancer cell lines that 
by definition exhibit abnormal cell cycle progression, 
also display abnormal circadian clock gene expression 
[9, 10]. Furthermore, mouse knock out lines affecting 
certain core clock genes show an increased susceptibility 
to tumor formation [45, 46].  While expression of YB-1 
protein is frequently elevated in tumors, its precise role in 
tumorigenesis is still poorly understood. In human tumors, 
such as breast, lung and prostate cancer, elevated YB-1 
protein levels and nuclear localization [47] appear to be 
prognostic, indicating poor clinical outcome. Furthermore, 
the accumulation of YB-1 protein in the nucleus is 
associated with increased cell survival and multidrug 
resistance [31, 48]. However, YB-1 over-expression has 
Figure 6: Regulation of zf Cyclin A2 expression by zfYB-1. (A) Graphical representation of the real time bioluminescence assay 
results from PAC-2 (blue trace) and CLOCK1 DN cells (red trace) transfected with the cyclin A2 pr. luciferase reporter. The black trace 
(BLANK) represents the luminescence background of the cell plate. The bioluminescence in counts per second (CPS) is plotted on the y-axis 
and the ZT times on the x-axis. Results are plotted as the mean of 4 independent transfections. Gray bars indicate the corresponding dark 
periods. (B–C) In vitro luciferase assays in cells co-transfected with the cyclin A2 –pr. reporter and (B) 25, 50 and 100 ng of the 5xMyc-
zfYB-1 expression vector or (C) with 50 ng of the zfYB-1-GFP, 5xMyc-zfYB-1 or the hYB-1-GFP expression vectors. Data are represented as 
means of triplicate samples +/– SD. At least three independent experiments were analyzed. Data were standardized for transfection efficiency 
using a β-galactosidase assay. Statistical significance is indicated above the graph by asterisks (*). (D) Agarose gel showing the 447 bp DNA 
promoter product amplified from ChIP assays using primers shown in Supplementary Table S2. Input and negative controls are indicated.
Oncotarget6201www.impactjournals.com/oncotarget
also been reported to block oncogenic transformation 
[49]. These apparently contradictory results may be the 
consequence of differential sub-cellular localization. 
Specifically, in the cytoplasm YB-1 may interfere with 
oncogenic transformation as a result of its function in 
translational control [25, 50]. YB-1 regulates the expression 
of several tumor-associated genes [51, 52]. As a result, 
elevated levels of YB-1 may play a role in facilitating 
tumor cell invasion and metastasis, as well as enhancing 
cell growth and resistance to chemotherapeutic agents. 
Thus, it is tempting to speculate that disruption of normal 
circadian rhythmicity of YB-1 function may serve as a key 
link with tumorogenesis.
MATERIALS AND METHODS
Fish care, treatment and ethical statements
Zebrafish (D. rerio) were maintained according to 
standard procedures [53] in a re-circulating water system 
at 28°C and under 14:10 light : dark cycles. For each 
experiment 6–12 months old zebrafish males or females 
were used. Under constant darkness, the fish were fed twice 
daily at random time points using automatic feeders. The 
caudal fins were amputated using razor blades following 
anesthesia with 0.02% w/v MS222 (3-aminobenzoate 
methanesulfonic acid, Sigma Aldrich). All zebrafish 
husbandry and experimental procedures were performed 
in accordance with the German animal protection 
standards (Animal Protection Law, BGBl. I, 1934 (2010)) 
and were approved by the Local Government of Baden-
Wurttemberg, Karlsruhe, Germany (Az.: 35-9185.81/G-
130/12 and 35-9185.81/G-131/16). General license for fish 
maintenance and breeding: Az.: 35-9185.64).
Quantitative RT-PCRs 
Total RNA was extracted with Trizol Reagent 
(Gibco, BRL) according to the manufacturer’s 
instructions. Reverse transcription was performed using 
Superscript III RT (Invitrogen). A StepOnePlus Real-Time 
qRT-PCR System (Applied Biosystems) and SYBR Green 
I fluorescent dye (Promega) were used. Expression levels 
were normalized using zf β-actin and h-gapdh mRNA 
expression for zebrafish and human HEK 293 cells, 
respectively. The relative levels of mRNA were calculated 
using the 2−ΔΔCT method. For each gene, primer sequences 
are presented in Supplementary Table S2.
RNA interference
zfYB-1, NM_001126457, transient silencing was 
carried out in PAC-2 cells with increasing concentrations 
of IBONI YB-1 siRNA (RIBOXX GmbH, Germany) 
and FuGene HD reagent (Promega) according to the 
manufacturers’ recommendations. iBONi siRNA Negative 
Control was provided by Riboxx as a pool of 3 different 
siRNA. In Supplementary Table S3, all the siRNA 
sequences utilized are presented.
Protein analysis 
Nuclear and cytoplasmic protein extracts were 
obtained using the NP40 lysis buffer protocol as described 
elsewhere [54]. Total protein extracts were also prepared 
by directly adding 200 μl of 1X Laemmli buffer (6% SDS, 
20% glycerol, 125 mM TrispH6.8, 0,01% bromophenol 
blue, 100 mM DTT) including 1× cocktails of protease and 
phosphatase inhibitors (Sigma Aldrich) to the fin tissue 
or the cells. Gel electrophoresis was performed in a SDS 
polyacrylamide gel and proteins transferred to a Hybond-P 
membrane (Millipore). Binding of each antibody was 
visualized using the ECL detection system (Biorad). All 
images were acquired and analyzed with Image Lab™ 
Software (Bio Rad, USA) or with X-Ray films (Kodak). 
Then, images were quantified using the Scion Image 
software (NIH, http://rsb.info.nih.gov/nih-image/). A list 
of the primary and secondary antibodies used is shown 
in Supplementary Table S4. YB-1 immunofluorescence 
analysis of fins was performed after overnight fixation 
of fin-clips in Carnoy’s solution (60% ethanol, 30% 
chloroform, 10% acetic acid) at 4°C followed by an 
incubation overnight in 100% Methanol and sequential 
rehydration steps in 100%, 66% and 33% methanol in 
PBTX (1XPBS, 0,3% Triton X100). Instead, adherent 
cells (1.2 × 105) were fixed overnight at 4°C in 4% PFA in 
1× PBS and then transferred to PBST (1X PBS plus 0,1% 
Tween 20). At this stage, fins and cells were pre-incubated 
in blocking solution (PBTX and PBST, respectively plus 
1% BSA (GE healthcare) for 3 hrs. Then the primary 
antibody was added and the samples were incubated 
at 4°C overnight.  After several washes, the samples 
were incubated at 4°C with the secondary fluorescent 
antibody (Supplementary Table S4) for 2 hours (cells) or 
overnight (fins). DAPI staining was used for visualization 
of nuclei. The samples were mounting on glass slides 
and photographed using a Confocal Microscope SPE 
(Leica) with a 40X oil immersion objective and the 
quantification of nuclear and cytoplasmic signals was 
calculated using Image Lab™ Software (Bio Rad, USA). 
Co-Immunoprecipitations (Co-IPs) were performed as 
previously described [32]. The antibody concentrations 
used in each IPs and for western blotting analysis were 
chosen according to the manufacturers’ recommendations.
Cell cultures and clock entrainment
The zebrafish cell line PAC-2 [55] was propagated 
as previously described [56]. 
The zebrafish CLOCK1 DN cells were a kind gift 
of David Whitmore and were propagated as previously 
described [34]. The HEK293 (human embryonic kidney 
derived) cell line was cultured at 37°C with 5% CO2 
in Dulbecco’s Modified Eagle’s Medium (DMEM) 
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containing 10% heat inactivated fetal calf serum (FCS), 
2 mM L-glutamine, 50 µg/ml penicillin and 50 µg/ml 
streptomycin.
The circadian clock in zebrafish cells was entrained 
by direct exposure of the cells to light–dark cycles at a 
constant temperature of 25°C using white light emitting 
diodes (LED, Kopa 440 nm-690 nm) adjusted to deliver 
a photon flux of 1.42 × 1018 ± 0,04 ×1018 photons/s/m2 · 
The clock entrainment in the HEK293 cells 
was performed by plating the cells at a concentration 
of 2.5 × 106 in DMEM medium (Sigma-Aldrich) in 
the presence of 10% serum. At 80% confluence, the 
concentration of serum was reduced to 2%. After 24 h, 
the cultures were treated with 100 nM water-soluble 
dexamethasone (Sigma-Aldrich) to synchronize the cells 
(time = 0 h), and after 2 h of incubation the medium was 
replaced with DMEM culture medium containing 2% 
serum. All cultures were incubated at 37°C in a humidified 
5% CO2 atmosphere until harvesting at specific time 
points after dexamethasone treatment (from 12 h to 48 h) 
according to the specific analysis.
FACS analysis for flow cytometry 
Cells were trypsinized, collected and washed two 
times in cold 1x PBS via centrifugation at 1200 rpm for 
4 minutes at 4°C. Next, the cell pellets were resuspended 
in 0.5 ml of ice-cold 100% methanol and incubated on 
ice for 20 minutes. After centrifugation at 1200 rpm for 
4 minutes at 4°C, the pellets were resuspended again in 
cold 1× PBS and incubated on ice for 30 minutes prior 
to centrifugation and final resuspension in 0.5 ml of 1× 
PBS in the presence of RNAase at a final concentration of 
100 ug/ml. After 20 minutes of incubation in RNAase at 
room temperature, the samples were finally stained with 
50 ug/ml of Propidium iodide (PI) (Sigma) for 30 minutes 
on ice and in darkness. Data acquisition and analysis of 
the cell cycle phases were performed using a BD Accury 
C6 cytometer and software from BD Biosciences. Each 
time point was analyzed in triplicate, 40.000 events were 
analyzed for each sample.
Luciferase assays 
Cell transfections were performed using FuGene 
HD (Promega) or ScreenFect (S-4001 InCella) reagents 
according to the manufacturers’ protocols. β-galactosidase 
expression was used to normalize for transfection 
efficiency using a standard protocol [57]. Luciferase 
activity was measured using the Luciferase Assay System 
kit (Promega) and a VICTOR Multilabel Plate Reader 
(Perkin Elmer). The real-time bioluminescence assays 
were performed and analyzed as described previously 
[56, 58]. Bioluminescence was assayed with a Topcount 
NXT automatic scintillation counter (Perkin Elmer). Data 
were imported into Microsoft Excel using the ‘‘Import and 
Analysis’’ macro (S. Kay, Scripps Research Institute).
Constructs
The expression constructs 5xMyc-zfYB-1 and 
zfYB-1–GFP and the zfcyclin A2 promoter were cloned 
by PCR amplification of PAC-2 cell DNA using pfu 
polymerase (Promega) and then subcloned into the 
pCS2-MTK 5xMyc (Invitrogen), pcDNA6-V5/HisB 
GFP (ThermoFisher) and pGL3 basic-Luc (Promega) 
expression vectors (see Supplementary Table S5 for 
details). The hYB-1-GFP expression vector was previously 
described (24). The p3259 pCMV hUBC 9 mt HA was a 
gift from Peter Howley ADDGENE (14439) [59]. 
Chromatin immunoprecipitation (ChIP)
The ChIP assay was performed as described 
previously [60] with some minor changes described 
below. In brief, 1 × 106 cells were seeded and then, after 
24 hours were fixed for 15 min. at room temperature in 
1× formaldehyde solution (HCOH 1%, NaCl 10 mM, 
EDTA 0.1 mM, EGTA 0.05 mM, Hepes 5 mM in L-15 
cell medium). After cell lysis in buffer L1 (Tris-HCl 
50 mM pH 8.0, EDTA 0.2 mM pH 8.0, NP40 0.1%, 
Glycerol 10% including a 1× cocktail of protease and 
phosphatase inhibitors (Sigma Aldrich)), the nuclei were 
recovered by centrifugation (5 min. at 4°C at 3000 rpm) 
and resuspended in lysis buffer L2 (Tris-HCl 50 mM pH 
8.0, EDTA 5 mM, SDS 1%). The sonicated chromatin 
(8 × 5s pulses) solution was diluted to a final volume of 
3 ml with DB buffer (Tris-HCl 50 mM pH 8.0, EDTA 
5 mM, NaCl 200 mM, NP40 0.5%). For each test (α-YB-1, 
no antibody (Ab) and α-IgG controls), 1 ml of chromatin 
solution was used. Immunoprecipitation was performed 
at 4°C over-night on a rotating platform. The antibody 
concentration was chosen according to the manufacturer’s 
instructions. To recover the immunocomplexes (antibody 
plus chromatin) we used magnetic beads (Dyna beads 
Protein G, ref. 1004D, Novex Life-Technology). After 
extensive washing, bound DNA fragments were eluted 
and subsequently analyzed by PCR. PCR primers are 
reported in Supplementary Table S1. The 150 bp or 
450 bp PCR products were visualized by 2% Agarose Gel 
Electrophoresis.
Statistical analysis
CircWaveBatch 3.3 (by courtesy of Dr. Roelof Hut, 
http://www.euclock.org/component/zoo/item/deliverables.
html) was used to identify sinusoidal differential 
expression during the 24-hour cycle. This statistical 
algorithm tests each expression profile against a harmonic 
curve by varying the phase and period length. A F-test was 
used to measure the goodness-of-fit and the transcript was 
considered rhythmic when the harmonic regression was 
statistically significant (p < 0.05). Results of the CircWave 
analysis are represented in Supplementary Table S1. 
One-way analysis of variance (ANOVA) followed by 
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Bonferroni’s multiple comparison tests was also performed 
using GraphPad Prism 4.0 (http://www.graphpad.com). 
Statistical analysis of the real time bioluminescence 
data from the cyclin A2 luciferase reporter construct 
was performed using the MATLAB R2015b software as 
follows: Each night/day cycle was processed separately. 
A regression routine of order one delivered a mean slope 
per cycle. Equal cycles were averaged per well. To obtain 
cycle changes between night and day, the mean slope 
of all cycles was subtracted. A t-test for differences was 
analysed (see Supplementary Table S1). 
All the statistical results are expressed as means 
+/– SD of three biological replicates where for each 
in vivo experiment a minimum of n = 3 fish were used per 
timepoint. In the statistical tests p < 0.05 was considered 
statistically significant. In each figure, p < 0.05, p < 0.001 
and p < 0.0001 are represented by *, ** and *** 
respectively. 
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